Libra Infusions Limited (DSE:LIBRAINFU)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
643.10
-8.70 (-1.33%)
At close: Dec 4, 2025
-30.04%
Market Cap 1.45B
Revenue (ttm) 197.03M
Net Income (ttm) 1.58M
Shares Out 2.25M
EPS (ttm) 0.70
PE Ratio 914.58
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,996
Average Volume 6,615
Open 651.90
Previous Close 651.80
Day's Range 640.00 - 653.10
52-Week Range 594.20 - 936.00
Beta -0.45
RSI 42.34
Earnings Date n/a

About Libra Infusions

Libra Infusions Limited manufactures and sells injectable intravenous fluids in Bangladesh. Its products are used in medical situations, including diuresis, surgical intervention, intoxication, sodium deficit, infections, and weakness. The company was formerly known as Libra Pharmaceutical Limited and changed its name to Libra Infusions Limited in 1999. Libra Infusions Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh. [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 699
Stock Exchange Dhaka Stock Exchange
Ticker Symbol LIBRAINFU
Full Company Profile

Financial Performance

In 2019, Libra Infusions's revenue was 197.03 million, an increase of 3.31% compared to the previous year's 190.72 million. Earnings were 1.58 million, a decrease of -72.49%.

Financial Statements

News

There is no news available yet.